Search Within

Andrea Knezevic

Formats
  1. Journal Article (53)
  2. Meeting Abstract (53)
  3. Research Letter (1)
Groups
  1. Department of Medicine (94)
  2. Solid Tumor Oncology Division (76)
  3. Genitourinary Oncology Service (64)
  4. Weinberg Fellows (61)
  5. Epidemiology and Biostatistics (58)
  6. Biostatistics Service (49)

More Groups

People
  1. Darren Feldman (52)
  2. Robert Motzer (48)
  3. Martin Voss (39)
  4. Chung-Han Lee (33)
  5. Maria Carlo (31)
  6. Ritesh Kotecha (27)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (12)
  4. 2022 (14)
  5. 2021 (8)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (39)
  2. Cancer (4)
  3. Clinical Genitourinary Cancer (4)
  4. Biology of Blood and Marrow Transplantation (3)
  5. Blood (3)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. Elsevier Inc. (14)
  3. American Association for Cancer Research (7)
  4. Wiley Blackwell (7)
  5. Springer (6)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Matched molecular profiling of cell-free DNA and tumor tissue in patients with advanced clear cell renal cell carcinoma
    Journal Article

    Kotecha, R. R.; Gedvilaite, E.; Ptashkin, R.; Knezevic, A.; Murray, S.; Johnson, I.; Shapnik, N.; Feldman, D. R.; Carlo, M. I.; Shah, N. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Meeting Abstract

    Manning-Geist, B.; Deng, L.; Knezevic, A.; Bromberg, M.; Funt, S.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; Gardner, G.; Grisham, R.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade
    Journal Article

    Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Fernandes, M. C.; Funt, S. A.; Bromberg, M.; Knezevic, A.; Nikolovski, I.; Feldman, D. R.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management
    Meeting Abstract

    Truong, H.; Ravichandran, V.; Kemel, Y.; Knezevic, A.; Gleeson, J. P.; Benfante, N.; Bromberg, M.; Bolos, M.; Joseph, G.; Matulewicz, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of adrenal insufficiency (AI) due to anti-PD(L)-1 immune checkpoint inhibitors (ICI) among patients with cancer
    Meeting Abstract

    Nguyen, B.; Shah, N. J.; Knezevic, A.; Newman, S.; Fitzgerald, K. N.; Kotecha, R.; Lee, C. H.; Carlo, M. I.; Aggen, D. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)
    Meeting Abstract

    Gleeson, J. P.; Harrold, E.; Bromberg, M.; Patel, Z.; Knezevic, A.; Thomas, T.; Ravichandran, V.; Tran, C.; Silber, D.; Carver, B. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy (PFS-2) for metastatic clear cell renal cell carcinoma (ccRCC) in patients treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)Lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Adintori, P. A.; Knezevic, A.; Devlin, S. M.; Buchan, M. L.; Preston, E. V.; Lin, A. P.; Rodriguez, N. T.; Carino, C. A.; more...
    Cancer (2022)

    Fulltext@MSK | Save